Hepatitis C Virus-Induced Monocyte Differentiation Into Polarized M2 Macrophages Promotes Stellate Cell Activation via TGF-beta
| dc.contributor.author | Saha, Banishree | |
| dc.contributor.author | Kodys, Karen | |
| dc.contributor.author | Szabo, Gyongyi | |
| dc.date | 2022-08-11T08:09:21.000 | |
| dc.date.accessioned | 2022-08-23T16:27:12Z | |
| dc.date.available | 2022-08-23T16:27:12Z | |
| dc.date.issued | 2016-01-08 | |
| dc.date.submitted | 2017-05-25 | |
| dc.identifier.citation | Cell Mol Gastroenterol Hepatol. 2016 Jan 8;2(3):302-316.e8. 10.1016/j.jcmgh.2015.12.005. eCollection 2016 May. <a href="https://doi.org/10.1016/j.jcmgh.2015.12.005">Link to article on publisher's site</a> | |
| dc.identifier.issn | 2352-345X (Linking) | |
| dc.identifier.doi | 10.1016/j.jcmgh.2015.12.005 | |
| dc.identifier.pmid | 28090562 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/36728 | |
| dc.description.abstract | BACKGROUND and AIMS: Monocyte and macrophage (MPhi) activation contributes to the pathogenesis of chronic hepatitis C virus (HCV) infection. Disease pathogenesis is regulated by both liver-resident MPhis and monocytes recruited as precursors of MPhis into the damaged liver. Monocytes differentiate into M1 (classic/proinflammatory) or M2 (alternative/anti-inflammatory) polarized MPhis in response to tissue microenvironment. We hypothesized that HCV-infected hepatoma cells (infected with Japanese fulminant hepatitis-1 [Huh7.5/JFH-1]) induce monocyte differentiation into polarized MPhis. METHODS: Healthy human monocytes were co-cultured with Huh7.5/JFH-1 cells or cell-free virus for 7 days and analyzed for MPhi markers and cytokine levels. A similar analysis was performed on circulating monocytes and liver MPhis from HCV-infected patients and controls. RESULTS: Huh7.5/JFH-1 cells induced monocytes to differentiate into MPhis with increased expression of CD14 and CD68. HCV-MPhis showed M2 surface markers (CD206, CD163, and Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN)) and produced both proinflammatory and anti-inflammatory cytokines. HCV-induced early interleukin 1beta production promoted transforming growth factor (TGF)beta production and MPhi polarization to an M2 phenotype. TGF-beta secreted by M2-MPhi led to hepatic stellate cell activation indicated by increased expression of collagen, tissue inhibitor of metalloproteinase 1, and alpha-smooth muscle actin. In vivo, we observed a significant increase in M2 marker (CD206) expression on circulating monocytes and in the liver of chronic HCV-infected patients. Furthermore, we observed the presence of a unique collagen-expressing CD14+CD206+ monocyte population in HCV patients that correlated with liver fibrosis. CONCLUSIONS: We show an important role for HCV in induction of monocyte differentiation into MPhis with a mixed M1/M2 cytokine profile and M2 surface phenotype that promote stellate cell activation via TGF-beta. We also identified circulating monocytes expressing M2 marker and collagen in chronic HCV infection that can be explored as a biomarker. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28090562&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.rights | Copyright © 2016 The Authors. | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | APC | |
| dc.subject | antigen-presenting cell | |
| dc.subject | Biomarkers | |
| dc.subject | CD206 | |
| dc.subject | COL | |
| dc.subject | collagen | |
| dc.subject | Collagen | |
| dc.subject | FITC | |
| dc.subject | fluorescein isothiocyanate | |
| dc.subject | Fibrocytes | |
| dc.subject | HCV | |
| dc.subject | hepatitis C virus | |
| dc.subject | HSC | |
| dc.subject | hepatic stellate cell | |
| dc.subject | Huh7.5/JFH-1 | |
| dc.subject | Huh7.5 cells infected with JFH-1 (HCV) | |
| dc.subject | IL | |
| dc.subject | interleukin | |
| dc.subject | IL1RA | |
| dc.subject | IL1-receptor antagonist | |
| dc.subject | JFH-1 | |
| dc.subject | Japanese fulminant hepatitis-1 | |
| dc.subject | MFI | |
| dc.subject | mean fluorescence intensity | |
| dc.subject | MΦ | |
| dc.subject | macrophage | |
| dc.subject | NEAA | |
| dc.subject | nonessential amino acid | |
| dc.subject | PBMC | |
| dc.subject | peripheral blood mononuclear cell | |
| dc.subject | PE | |
| dc.subject | Phycoerythrin | |
| dc.subject | TGF | |
| dc.subject | transforming growth factor | |
| dc.subject | TIMP | |
| dc.subject | tissue inhibitor of metalloproteinase | |
| dc.subject | TNF | |
| dc.subject | tumor necrosis factor | |
| dc.subject | mRNA | |
| dc.subject | messenger RNA | |
| dc.subject | α-SMA | |
| dc.subject | α-smooth muscle actin | |
| dc.subject | Cell Biology | |
| dc.subject | Cellular and Molecular Physiology | |
| dc.subject | Gastroenterology | |
| dc.subject | Hepatology | |
| dc.subject | Immunology and Infectious Disease | |
| dc.subject | Molecular Biology | |
| dc.title | Hepatitis C Virus-Induced Monocyte Differentiation Into Polarized M2 Macrophages Promotes Stellate Cell Activation via TGF-beta | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Cellular and molecular gastroenterology and hepatology | |
| dc.source.volume | 2 | |
| dc.source.issue | 3 | |
| dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1094&context=metnet_pubs&unstamped=1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/metnet_pubs/95 | |
| dc.identifier.contextkey | 10212160 | |
| refterms.dateFOA | 2022-08-23T16:27:12Z | |
| html.description.abstract | <p>BACKGROUND and AIMS: Monocyte and macrophage (MPhi) activation contributes to the pathogenesis of chronic hepatitis C virus (HCV) infection. Disease pathogenesis is regulated by both liver-resident MPhis and monocytes recruited as precursors of MPhis into the damaged liver. Monocytes differentiate into M1 (classic/proinflammatory) or M2 (alternative/anti-inflammatory) polarized MPhis in response to tissue microenvironment. We hypothesized that HCV-infected hepatoma cells (infected with Japanese fulminant hepatitis-1 [Huh7.5/JFH-1]) induce monocyte differentiation into polarized MPhis.</p> <p>METHODS: Healthy human monocytes were co-cultured with Huh7.5/JFH-1 cells or cell-free virus for 7 days and analyzed for MPhi markers and cytokine levels. A similar analysis was performed on circulating monocytes and liver MPhis from HCV-infected patients and controls.</p> <p>RESULTS: Huh7.5/JFH-1 cells induced monocytes to differentiate into MPhis with increased expression of CD14 and CD68. HCV-MPhis showed M2 surface markers (CD206, CD163, and Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN)) and produced both proinflammatory and anti-inflammatory cytokines. HCV-induced early interleukin 1beta production promoted transforming growth factor (TGF)beta production and MPhi polarization to an M2 phenotype. TGF-beta secreted by M2-MPhi led to hepatic stellate cell activation indicated by increased expression of collagen, tissue inhibitor of metalloproteinase 1, and alpha-smooth muscle actin. In vivo, we observed a significant increase in M2 marker (CD206) expression on circulating monocytes and in the liver of chronic HCV-infected patients. Furthermore, we observed the presence of a unique collagen-expressing CD14+CD206+ monocyte population in HCV patients that correlated with liver fibrosis.</p> <p>CONCLUSIONS: We show an important role for HCV in induction of monocyte differentiation into MPhis with a mixed M1/M2 cytokine profile and M2 surface phenotype that promote stellate cell activation via TGF-beta. We also identified circulating monocytes expressing M2 marker and collagen in chronic HCV infection that can be explored as a biomarker.</p> | |
| dc.identifier.submissionpath | metnet_pubs/95 | |
| dc.contributor.department | UMass Metabolic Network | |
| dc.contributor.department | Department of Medicine, Division of Gastroenterology | |
| dc.source.pages | 302-316.e8 |

